Francesca Jackson-Spence

7PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.

Francesca Jackson-Spence, James Larkin, Poulam Patel

|Jun 28, 2023
Top advances of the year: Genitourinary cancer.

Francesca Jackson-Spence, Matthew Young, Christopher Sweeney

|Apr 21, 2023
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery.

Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony

|Jan 11, 2022
Avelumab in locally advanced or metastatic urothelial carcinoma.

Francesca Jackson-Spence, Bernadett Szabados, Charlotte Toms

Pageof 2